37 results on '"Tompkins, Van S."'
Search Results
2. Identification of MYC intron 2 regions that modulate expression
3. Discovery of RNA secondary structural motifs using sequence-ordered thermodynamic stability and comparative sequence analysis
4. Thermodynamic and structural characterization of an EBV infected B-cell lymphoma transcriptome
5. Forkhead Box M1 Regulates Quiescence-Associated Radioresistance of Human Head and Neck Squamous Carcinoma Cells
6. HHV-8–encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice
7. Analyses of human cancer driver genes uncovers evolutionarily conserved RNA structural elements involved in posttranscriptional control
8. Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma
9. A map of the SARS-CoV-2 RNA structurome
10. Immunomodulatory drug and dexamethasone-containing triple versus doublet combination treatments for relapsed or refractory multiple myeloma: a meta-analysis of phase III randomized controlled trials
11. Differential expression analysis comparing EBV uninfected to infected human cell lines identifies induced non-micro small non-coding RNAs
12. RNA structural analysis of the MYC mRNA reveals conserved motifs that affect gene expression
13. Scans of the MYC mRNA reveal multiple stable secondary structures—including a 3′ UTR motif, conserved across vertebrates, that can affect gene expression
14. NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma
15. Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma
16. Lenalidomide after stem-cell transplantation for multiple myeloma: a meta-analysis of randomized controlled trials
17. PIAS1 Promotes Lymphomagenesis through MYC Upregulation
18. Abstract A04: The tumor microenvironment is the main source of IL-6 for plasmacytoma development in mice.
19. CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma
20. NIAM-Deficient Mice Are Predisposed to the Development of Proliferative Lesions including B-Cell Lymphomas
21. Early versus Deferred Treatment for Smoldering Multiple Myeloma: A Meta-Analysis of Randomized, Controlled Trials
22. Proteasome inhibitor carfilzomib interacts synergistically with histone deacetylase inhibitor vorinostat in Jurkat T-leukemia cells
23. Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53
24. RABL6A, a Novel RAB-Like Protein, Controls Centrosome Amplification and Chromosome Instability in Primary Fibroblasts
25. Identification of Candidate B-Lymphoma Genes by Cross-Species Gene Expression Profiling
26. Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells
27. Abstract B38: Targeting FOXM1 in multiple myeloma
28. Abstract 712: Parf-1A (Partner of ARF isoform 1A) promotes oxaliplatin resistance and is a new prognostic marker of survival in pancreatic ductal adenocarcinoma
29. NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma
30. Adenovirus E1A oncoprotein liberates c‐Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1‐dependent mechanism
31. A Novel Nuclear Interactor of ARF and MDM2 (NIAM) That Maintains Chromosomal Stability
32. CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.
33. NF-κB/STAT3/PI35 signaling crosstalk in iMyc&EµB lymphoma.
34. RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients
35. RNA structural analysis of the MYC mRNA reveals conserved motifs that affect gene expression.
36. Lenalidomide after stem-cell transplantation for multiple myeloma: a meta-analysis of randomized controlled trials.
37. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.